ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase II trial of prolonged infusion gemcitabine as second line treatment in non-small cell lung cancer
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7316
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7316-7316
Author(s):
M. B. Kleinman
◽
I. Stewart
◽
S. Ratmanskiy
◽
M. Gayle
◽
P. Bonomi
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Prolonged Infusion
Download Full-text
Related Documents
Cited By
References
Phase II trial of prolonged infusion gemcitabine as second line treatment in non-small cell lung cancer
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.7316
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7316-7316
Author(s):
M. B. Kleinman
◽
I. Stewart
◽
S. Ratmanskiy
◽
M. Gayle
◽
P. Bonomi
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Prolonged Infusion
Download Full-text
A multicenter phase II trial with gemcitabine plus oxaliplatin as second line treatment in patients with advanced non-small cell lung cancer (NSCLC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7263
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7263-7263
Author(s):
C. Kouroussis
◽
K. Syrigos
◽
A. Potamianou
◽
N. Ziras
◽
P. Ziotopoulos
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
A phase II trial of single-agent vinflunine as second-line treatment for advanced non-small cell lung cancer (An International Oncology Network Study, #I-05–009)
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.19033
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 19033-19033
◽
Cited By ~ 1
Author(s):
M. Joppert
◽
M. Knapp
◽
S. R. Dakhil
◽
R. V. Boccia
◽
R. Steis
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Single Agent
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
Download Full-text
Lipoplatin™ Monotherapy: A Phase II Trial of Second-Line Treatment of Metastatic Non-Small-Cell Lung Cancer
Journal of Chemotherapy
◽
10.1179/joc.2009.21.1.86
◽
2009
◽
Vol 21
(1)
◽
pp. 86-90
◽
Cited By ~ 16
Author(s):
A. Ravaioli
◽
M. Papi
◽
E. Pasquini
◽
M. Marangolo
◽
B. Rudnas
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
Download Full-text
P-542 Carboplatin (C) and docetaxel (D) in the second-line treatment of non-small cell lung cancer (NSCLC) patients pretreated with platinum-based regimens. A Phase II trial
Lung Cancer
◽
10.1016/s0169-5002(05)81035-9
◽
2005
◽
Vol 49
◽
pp. S260
Author(s):
G. Numico
◽
L. Buffoni
◽
V. Dongiovanni
◽
M. Schena
◽
C. Fissore
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Nsclc Patients
Download Full-text
Phase II Trial of Temozolomide and Irinotecan as Second-Line Treatment for Advanced Non–small Cell Lung Cancer
Journal of Thoracic Oncology
◽
10.1016/s1556-0864(15)31575-6
◽
2006
◽
Vol 1
(3)
◽
pp. 245-251
◽
Cited By ~ 14
Author(s):
Nicholas W. Choong
◽
Ann M. Mauer
◽
Philip C. Hoffman
◽
Charles M. Rudin
◽
Jerome D. Winegarden
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
Download Full-text
Is Lipoplatinum Monotherapy an Active Alternative in Second Line Treatment of Metastatic Non–Small Cell Lung Cancer? A Phase II Trial
Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy
◽
10.1007/978-1-60327-459-3_29
◽
2009
◽
pp. 243-249
Author(s):
Alberto Ravaioli
◽
Manuela Fantini
◽
Fabrizio Drudi
◽
Maximilian Papi
◽
Enzo Pasquini
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
Download Full-text
A multicenter phase II trial with gemcitabine plus oxaliplatin as second line treatment in patients with advanced non-small cell lung cancer (NSCLC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.7263
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7263-7263
Author(s):
C. Kouroussis
◽
K. Syrigos
◽
A. Potamianou
◽
N. Ziras
◽
P. Ziotopoulos
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Multicenter Phase
Download Full-text
P-576 Phase II trial of weekly topotecan in the second-line treatment of small cell lung cancer
Lung Cancer
◽
10.1016/s0169-5002(03)92543-8
◽
2003
◽
Vol 41
◽
pp. S237
◽
Cited By ~ 8
Author(s):
F. Anthony Greco
◽
Howard A. Burris
◽
Denise Aysel Yardley
◽
John Daniel Hainsworth
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
Download Full-text
P48.05 Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2021.01.875
◽
2021
◽
Vol 16
(3)
◽
pp. S501
Author(s):
P. Deng
◽
H. Yang
◽
C. Chen
◽
C. Hu
◽
L. Cao
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Small Cell Lung
◽
Extensive Stage
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close